JPRN-UMIN000030932已完成未知
Optimal treatment strategy of mineralocorticoid receptor antagonists for primary aldosteronism - Optimal treatment strategy of mineralocorticoid receptor antagonists for primary aldosteronism
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who did not agree to this study, receiving sex hormone therapy, having heart diseases (NYHA 3 degree or higher), liver dysfunction (AST/ALT over 100IU/mL or T-Bil over 2.0mg/dL), renal dysfunction (Cr over 2.0mg/dL), serious diseases such as malignant diseases and judged inappropriate.
研究者
相似试验
进行中（未招募）
不适用
Effects of eplerenone on forearm blood flowhealthy volunteersEUCTR2013-000189-12-NLniversity Medical Centre Nijmegen
已完成
不适用
Effects of the selective mineralocorticoid receptor antagonist eplerenone on extracellular adenosine formation in humans in vivoblood flowischemia reperfusion injury10011082NL-OMON38928niversitair Medisch Centrum Sint Radboud14
尚未招募
2 期
Effects of Mineralocorticoid Receptor Blockade on Metabolism - A Clinical TrialMetabolic and Endocrine - Metabolic disordersDiet and Nutrition - ObesityObesityACTRN12618001958279Dr Moe Thuzar32
已完成
不适用
Proactive management with topical corticosteroids ointment in pediatric atopic dermatitis : Superiority to rank-down therapyatopic dermatitisJPRN-UMIN000031979Jichi Medical University School of Medicine90
进行中（未招募）
1 期
MINeralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-Elevation Myocardial Infarction (STEMI)Cardiovascular diseaseEUCTR2013-001069-18-GBniversity College London (UCL)150